+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID06996574

Study Comparing an All-in-One Procedure to At-Home Screening Trials for Chronic Neuropathic Pain Using Closed-Loop Spinal Cord Stimulation

Led by Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · Updated on 2025-07-10

180

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the effectiveness and cost utility of an all-in-one spinal cord stimulation SCS procedure compared to the standard two-step approach that includes an at-home screening trial. This pragmatic, multi-center, randomized non-inferiority trial focuses on adult patients in the Netherlands with chronic neuropathic pain conditions such as persistent spinal pain syndrome, painful diabetic neuropathy, complex regional pain syndrome, and small fibre neuropathy. The study aims to assess whether the all-in-one procedure is as effective as the traditional screening trial method, which can be costly and carry risks like infection. Participants are randomly assigned to either the all-in-one procedure group no trial group, NTG or the standard two-phase closed-loop SCS procedure with an at-home screening trial group trial group, TG. Both approaches involve closed-loop SCS, with the trial group undergoing a temporary screening trial to confirm at least 50% pain reduction before permanent implantation. The all-in-one group receives the full implantation procedure without prior screening. Treatments are delivered under everyday clinical practice settings to inform clinical decisions and health policy. During the study, participants will be monitored for changes in pain intensity using the Numeric Rating Scale NRS up to six months after lead implantation. They are also asked to complete additional trial-related questionnaires. Researchers will evaluate pain reduction and cost utility between the two approaches. The study includes single masking and randomization with follow-up visits and assessments to track outcomes and safety throughout the trial period, which begins in June 2025 and is expected to conclude by April 2028.

CONDITIONS

Brief Title

Study to Compare the Clinical Effectiveness and Cost Utility of an All-in-one Procedure With an At-home Screening Trial

Research Team

E

E de Klerk S drs., Master of Science

C

Carin Wensing drs, Master of Science

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here